Medtronic Infuse Settlement Agreement Reached For $22M
Medtronic has agreed to pay about $22 million to settle about 950 Infuse BMP lawsuits filed on behalf of individuals nationwide who have experienced problems after receiving the bone graft product....
View ArticleBayer to Share Clinical Trial Data Amid Push for Transparency
Amid an ongoing push for more transparency, Bayer Healthcare has agreed to share some patient-level clinical trial data, provided that the test subjects’ anonymity is maintained. Bayer has agreed to...
View ArticleSettlements for Medtronic Infuse Bone Growth Lawsuits Cut Into Q4 Profits
It appears that costs associated with Medtronic Infuse bone graft lawsuits, including millions that may be paid to settle hundreds of claims, are cutting into the profits for the medical device...
View ArticleResearchers Call For Open Access to Clinical Trial Data
Amid questions over the validity of studies used by drug manufacturers to obtain approval for new medications, some researchers are calling for open access to all clinical trial data. In an editorial...
View ArticleNew Rules Proposed For Conducting Clinical Drug Trials
Federal health experts have proposed new rules regarding clinical drug trials, seeking to significantly expand how much information researchers and drug companies must provide to the public. A special...
View ArticleSide Effects of Bone Graft Substitutes Linked to Child Health Risks, FDA Warns
Federal drug regulators are warning against the use of bone graft substitutes, such Medtronic Infuse, among children, indicating that the bone growth proteins have been linked to reports of serious...
View ArticleMedtronic Infuse Lawsuit Appealed to U.S. Supreme Court Over Off-Label Marketing
The U.S. Supreme Court is being asking to review whether Medtronic is still able to seek immunity from failure to warn claims under federal preemption due to FDA approval of their Infuse bone growth...
View ArticleMedtronic Infuse Problems Hidden From Regulators, Report Claims
A new report suggests that Medtronic failed to adequately inform federal regulators about more than 1,000 adverse event reports linked to its Infuse bone growth product for years, including at least...
View ArticleMedtronic Settlement Reached Over Claims Infuse Bone Graft Studies Were...
A $43 million settlement was reached last week by Medtronic, resolving a class action lawsuit filed by investors over claims that the company manipulated studies involving its controversial Infuse bone...
View ArticleMedtronic Infuse Linked To Neck Problems In Data Kept From FDA For Years
According to a new investigative report, Medtronic may have hidden away dozens of reports involving problems with Infuse bone growth implants for years, including reports that the the product caused...
View Article
More Pages to Explore .....